Haploid loss of Ki-ras delays mammary tumor progression in C3 (1)/SV40 Tag transgenic mice
暂无分享,去创建一个
[1] Kenji Nakamura,et al. Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis , 2000, Oncogene.
[2] Cheryl Jorcyk,et al. The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma , 2000, Oncogene.
[3] A. Roberts,et al. Heterotopic endochondrial ossification with mixed tumor formation in C3(1)/Tag transgenic mice is associated with elevated TGF-beta1 and BMP-2 expression , 1999, Oncogene.
[4] T. Ried,et al. Amplification of Ki-ras and elevation of MAP kinase activity during mammary tumor progression in C3(1)/SV40 Tag transgenic mice , 1998, Oncogene.
[5] W. Yung,et al. Overexpression of E2F‐1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo , 1998, Nature Medicine.
[6] R. Kucherlapati,et al. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. , 1997, Genes & development.
[7] J. Ward,et al. p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinoma. , 1996, Cancer research.
[8] J. Green,et al. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[9] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[10] R. Lidereau,et al. Point mutation at codon 12 of the Ki-ras gene in a primary breast carcinoma and the MDA-MB-134 human mammary carcinoma cell line. , 1990, Cancer letters.
[11] M. Aapro,et al. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas. , 1989, Cancer research.
[12] D. George,et al. Enhanced c-Ki-ras expression associated with Friend virus integration in a bone marrow-derived mouse cell line. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[13] D. Slamon,et al. Expression of p21 ras oncoproteins in human cancers. , 1986, Cancer research.
[14] J. L. Bos,et al. A human gastric carcinoma contains a single mutated and an amplified normal allele of the Ki-ras oncogene. , 1986, Nucleic acids research.
[15] H. Varmus,et al. Identification of a provirally activated c‐Ha‐ras oncogene in an avian nephroblastoma via a novel procedure: cDNA cloning of a chimaeric viral‐host transcript. , 1986, The EMBO journal.
[16] J. Filmus,et al. Stability of c-K-ras amplification during progression in a patient with adenocarcinoma of the ovary. , 1985, Cancer research.
[17] J. Rhim,et al. Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[18] Jeffrey,et al. Varying degrees of amplification of the N-ras oncogene in the human breast cancer cell line MCF-7. , 1985, Cancer research.
[19] P. Seeburg,et al. Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations , 1983, Nature.
[20] Jeffrey E. Green,et al. Suppression of mammary carcinoma growth in vitro and in vivo by inducible expression of the Cdk inhibitor p21 , 2001, Cancer Gene Therapy.